MeSH term
Frequency | Condition_Probility | Apoptosis | 2 | 0.0 |
Cell Line | 3 | 0.0 |
Humans | 20 | 0.0 |
Phosphorylation | 6 | 0.0 |
Precipitin Tests | 2 | 0.0 |
Protein-Serine-Threonine Kinases/metabolism | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 5 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 9 | 0.0 |
Animals | 6 | 0.0 |
Cell Survival | 2 | 0.0 |
Mice | 3 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
*Protein-Serine-Threonine Kinases | 8 | 0.0 |
*Signal Transduction | 2 | 0.0 |
1-Phosphatidylinositol 3-Kinase/antagonists & inhibitors/metabolism | 4 | 4.0 |
Blotting, Western | 2 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
Female | 7 | 0.0 |
Research Support, Non-U.S. Gov't | 16 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
DNA Primers | 2 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Transfection | 2 | 0.0 |
Mutation | 2 | 0.0 |
Chromones/pharmacology | 4 | 1.0 |
Enzyme Activation | 3 | 0.0 |
Enzyme Inhibitors/pharmacology | 4 | 0.0 |
Morpholines/pharmacology | 4 | 1.0 |
Tumor Cells, Cultured | 7 | 0.0 |
Androstadienes/pharmacology | 2 | 0.0 |
Protein Isoforms | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Serine/metabolism | 2 | 0.0 |
Signal Transduction | 2 | 0.0 |
Adult | 2 | 0.0 |
Aged | 2 | 0.0 |
Male | 4 | 0.0 |
Middle Aged | 2 | 0.0 |
*Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Breast Neoplasms/genetics/*pathology | 2 | 4.0 |
